Search Results - "Isaji, Masayuki"
-
1
SGLT2 inhibitors: molecular design and potential differences in effect
Published in Kidney international (01-03-2011)“…The physiological and pathological handling of glucose via sodium–glucose cotransporter-2 (SGLT2) in the kidneys has been evolving, and SGLT2 inhibitors have…”
Get full text
Journal Article -
2
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models
Published in The Journal of pharmacology and experimental therapeutics (01-10-2008)“…The low-affinity sodium glucose cotransporter (SGLT2) plays an important role in renal glucose reabsorption and is a remarkable transporter as a molecular…”
Get more information
Journal Article -
3
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Published in The Journal of pharmacology and experimental therapeutics (01-01-2007)“…The low-affinity sodium glucose cotransporter (SGLT2), which is expressed specifically in the kidney, plays a major role in renal glucose reabsorption in the…”
Get more information
Journal Article -
4
Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation
Published in European journal of pharmacology (05-07-2017)“…Chronic constipation is a highly common functional gastrointestinal disorder that adversely affects patient quality of life. At present, limited therapeutic…”
Get full text
Journal Article -
5
KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models
Published in The Journal of pharmacology and experimental therapeutics (01-08-2012)“…The high-affinity sodium glucose cotransporter (SGLT1) plays a critical role in glucose absorption from the gastrointestinal tract. We have developed…”
Get more information
Journal Article -
6
Identification of Adenine and Benzimidazole Nucleosides as Potent Human Concentrative Nucleoside Transporter 2 Inhibitors: Potential Treatment for Hyperuricemia and Gout
Published in Journal of medicinal chemistry (28-04-2016)“…To test the hypothesis that inhibitors of human concentrative nucleoside transporter 2 (hCNT2) suppress increases in serum urate levels derived from dietary…”
Get full text
Journal Article -
7
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
Published in European journal of pharmacology (01-05-2009)“…The low-affinity sodium glucose cotransporter (SGLT2) is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel…”
Get full text
Journal Article -
8
Identification of 8‑Aminoadenosine Derivatives as a New Class of Human Concentrative Nucleoside Transporter 2 Inhibitors
Published in ACS medicinal chemistry letters (12-03-2015)“…Purine-rich foods have long been suspected as a major cause of hyperuricemia. We hypothesized that inhibition of human concentrative nucleoside transporter 2…”
Get full text
Journal Article -
9
Phlorizin Prevents Electrically-Induced Ventricular Tachyarrhythmia during Ischemia in Langendorff-Perfused Guinea-Pig Hearts
Published in Biological & pharmaceutical bulletin (2014)“…Phlorizin is a type of flavonoids and has a peroxynitrite scavenging effect. This study aimed to elucidate the effects of phlorizin on ischemia-induced…”
Get full text
Journal Article -
10
Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin
Published in Metabolism, clinical and experimental (01-08-2005)“…Obese (fa/fa) Zucker rat is a spontaneous genetic obesity model and, by comparison with lean Zucker rat, exhibits hyperphagia, hyperinsulinemia, and…”
Get full text
Journal Article -
11
Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo
Published in British journal of pharmacology (01-11-1997)“…1 First developed as an antiallergic drug, tranilast inhibits chemical mediator release from mast cells. In the present study, we examine the effects of…”
Get full text
Journal Article -
12
Sodium-glucose cotransporter inhibitors for diabetes
Published in Current opinion in investigational drugs (London, England : 2000) (01-04-2007)“…In the search for potential new drug targets for the treatment of diabetes, sodium-glucose cotransporters (SGLTs), in particular SGLT2, have been the subject…”
Get more information
Journal Article -
13
Rat model of the hypercalcaemia induced by parathyroid hormone-related protein: characteristics of three bisphosphonates
Published in European journal of pharmacology (10-01-2005)“…In our preliminary experiment, we found that a constant infusion of a high dose of parathyroid hormone-related protein induced both hyperphosphataemia and…”
Get full text
Journal Article -
14
Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
Published in Bioorganic & medicinal chemistry (15-03-2021)“…[Display omitted] We optimized the structure of an active metabolite (1) of WAY-123783, which was obtained from mouse urine after oral administration, to…”
Get full text
Journal Article -
15
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
Published in Journal of clinical and experimental hepatology (01-09-2015)“…Background Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH) are serious conditions and are being diagnosed at an increased rate. The…”
Get full text
Journal Article -
16
Inhibitory Effects of Tranilast on the Proliferation and Functions of Human Pterygium-derived Fibroblasts
Published in Cornea (01-05-2000)“…PURPOSE.We studied the possibility that tranilast, an antiallergic and antiproliferative drug, may be beneficial for the treatment of pterygium…”
Get full text
Journal Article -
17
Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats
Published in Life sciences (1973) (1998)“…We studied the effects of tranilast, an anti-allergic and anti-proliferative drug in clinical use, on VEGF/VPF-induced vascular permeability in a rat air pouch…”
Get full text
Journal Article -
18
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice
Published in European journal of pharmacology (15-09-2009)“…Sergliflozin etabonate, a novel oral selective low-affinity sodium glucose cotransporter (SGLT2) inhibitor, improves hyperglycemia by suppressing renal glucose…”
Get full text
Journal Article -
19
Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides
Published in European journal of pharmacology (05-09-2012)“…We have developed concentrative nucleoside transporter 2 (CNT2) inhibitors as a novel pharmacological approach for improving hyperuricemia by inhibiting…”
Get full text
Journal Article -
20
Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase
Published in Journal of structural biology (01-03-2009)“…Catechol-O-methyltransferase (COMT, EC 2.1.1.6) is a monomeric enzyme that catalyzes the transfer of a methyl group from S-adenosyl-l-methionine (AdoMet) to…”
Get full text
Journal Article